Log In
BCIQ
Print this Print this
 

ALX148

  Manage Alerts
Collapse Summary General Information
Company Alexo Therapeutics Inc.
Description 
Molecular Target CD47
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today